Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Feb 14, 2011
The kidneys will be affected in approximately one-third of all cases with lupus. Diagnosing and monitoring lupus-related kidney disease, called lupus nephritis, often requires an invasive kidney biopsy. Dr. Amy Kao of the Allegheny-Singer Research Institute in Pittsburgh, has conducted a study, supported by the Lupus Foundation of America, on evaluation of CD4 molecules on T-cells as a possible marker for lupus nephritis. Validating such a biomarker for this potentially life-threatening complication of lupus would eliminate or greatly reduce the need for kidney biopsies. In this video, Dr. Kao discusses her study and future steps for this line of investigation.